# Endoscopic retrograde submucosal tunnel resection for cervical esophageal submucosal tumors via percutaneous gastrostomy: a conceptual approach

**Authors:** Conghua Song, Xiaomei Li

PMC · DOI: 10.3389/fmed.2025.1651473 · Frontiers in Medicine · 2025-10-28

## TL;DR

A new endoscopic technique is proposed to remove tumors in the cervical esophagus by accessing them from the stomach, potentially reducing complications.

## Contribution

A novel retrograde endoscopic approach is introduced to overcome anatomical limitations in cervical esophageal tumor resection.

## Key findings

- ER-STER could expand working space and reduce manipulation near the upper esophageal sphincter.
- The method introduces risks like PEG-related morbidity and mediastinal contamination.
- This conceptual approach requires further study to assess feasibility and safety.

## Abstract

Management of submucosal tumors (SMTs) or subepithelial lesions (SELs) at the cervical esophagus remains technically challenging due to limited maneuvering space and short oral mucosal length for conventional submucosal tunnel endoscopic resection (STER). We propose a novel conceptual approach—endoscopic retrograde submucosal tunnel resection (ER-STER)—which enables retrograde access to cervical esophageal SMTs through a percutaneous endoscopic gastrostomy (PG) and anal submucosal tunnel. This technique could potentially enlarge the working space and reduce manipulation near the upper esophageal sphincter (UES), while introducing uncertainties such as PEG-related morbidity, retrograde tunnel perforation, and mediastinal contamination risk. This hypothesis-generating article outlines the rationale, procedural concept, risk analysis, and a translational roadmap for ER-STER. By shifting tunnel entry to the anal side, ER-STER may address the anatomical limitations of conventional STER and reduce patient discomfort associated with proximal mucosal injury. While still theoretical, this method warrants further exploration for feasibility, safety, and clinical utility.

## Full-text entities

- **Genes:** EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}
- **Diseases:** esophageal submucosal tumors (MESH:D004938), mucosal injury (MESH:D052016), SMTs (MESH:D009369), SELs (MESH:C567547)
- **Chemicals:** PEG (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12602201/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12602201/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12602201/full.md

---
Source: https://tomesphere.com/paper/PMC12602201